Pine Haven Investment Counsel, Inc Gilead Sciences, Inc. Transaction History

Pine Haven Investment Counsel, Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 22, 2024	SELL	$73.27 - $83.09 $16,485 - $18,695	-225 Reduced 8.14%	2,539 $205,000
Q2 2023 Aug 02, 2023	SELL	$76.01 - $86.7 $36,484 - $41,616	-480 Reduced 14.8%	2,764 $213,000
Q1 2023 May 01, 2023	SELL	$77.31 - $88.08 $19,327 - $22,020	-250 Reduced 7.16%	3,244 $269,000
Q4 2022 Jan 17, 2023	SELL	$62.32 - $89.47 $32,219 - $46,255	-517 Reduced 12.89%	3,494 $0
Q3 2022 Nov 07, 2022	SELL	$59.54 - $68.01 $1,309 - $1,496	-22 Reduced 0.55%	4,011 $247,000
Q2 2022 Aug 10, 2022	BUY	$57.72 - $65.01 $57 - $65	1 Added 0.02%	4,033 $249,000
Q1 2022 May 09, 2022	SELL	$57.92 - $72.58 $12,626 - $15,822	-218 Reduced 5.13%	4,032 $240,000
Q4 2021 Feb 09, 2022	BUY	$64.88 - $73.64 $275,740 - $312,970	4,250 New	4,250 $309,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Pine Haven Investment Counsel, Inc, based on Form 13F filings with the SEC.

Stay updated on Pine Haven Investment Counsel, Inc with notifications on news.